Peter Gerald Malone bought $6,990 of IAF
director at ABRDN AUSTRALIA EQUITY FUND, INC.. 1,500 shares at an average of $4.66, traded Sep 26, 2025, filed Sep 30, 2025.
Score components
- +15RoleDirector
- 0Trade size$7k at market
- +10Relative to holdingsHoldings up 120%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.2%, 3m -2.4%, 6m -6.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-095047, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 26, 2025 | POpen-market purchase Common Stock | +1,500 | $4.66 | $6,990 | 2,750 | Sep 30, 2025 |
Related signals
Other insiders at ABRDN AUSTRALIA EQUITY FUND, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | IAFbuy ABRDN AUSTRALIA EQUITY FUND, INC. | Radhika Ajmera director | $4,094 910 shares | +60% | |
| 33Weak | ABRDN AUSTRALIA EQUITY FUND, INC. | Rahn K Porter director | $8,061 1,800 shares | +161% | |
| 33Weak | ABRDN AUSTRALIA EQUITY FUND, INC. | Moritz A Sell director | $9,000 2,000 shares | +200% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.